Peptabody for cancer treatment

Details for Australian Patent Application No. 2004226162 (hide)

International Classifications

Event Publications

3 November 2005 PCT application entered the National Phase

PCT publication WO2004/087766 Priority application(s): WO2004/087766

10 April 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

22 May 2008 Section 223 Application Allowed

Universite De Lausanne The time in which to request examination has been extended to 11 Apr 2008. Address for service in Australia - Hodgkinson McInnes Patents Level 21, 201 Elizabeth Street Sydney NSW 2000

28 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.